| Name | Surgical Innovations Group |
|---|---|
| Epic | SUN |
| Isin | GB0004016704 |
| Industry | Medical Equipment and Services |
| Latest share price | 0.63p | Net gearing | n/a |
|---|---|---|---|
| Market capitalisation | £5.91 | Debt ratio | n/a |
| Shares in issue | 932.82 | Debt-to-equity ratio | n/a |
| P/E ratio | n/a | Assets / equity ratio | n/a |
| Total dividends per share | n/a | Price to book value | n/a |
| Dividend yield | n/a | ROCE | -10.31 |
| Dividend cover | n/a | EPS growth | n/a |
| Earning per share | -0.06 | 52-week high / low | 0.40p / 1.30p |
| Type | Ex-date | Pay-date | Net-dividend |
|---|---|---|---|
| No dividends declared | |||
| Company name | Surgical Innovations Group |
|---|---|
| Address | Clayton Wood House, Clayton Wood Bank Rise, Leeds, United Kingdom, LS16 6QZ |
| Telephone | +44 (0) 113 230 7597 |
| Website | http://www.sigroupplc.com/ |
| Director | Position |
|---|---|
| Mr David Marsh | CEO |
| Mr Jonathan Glenn | Chairman |
| Mr Paul Hardy | Independent Non-Executive Director |
| Mr Keyvan Djamarani | Independent Non-Executive Director |
| Mr Chris Martin | CFO & Executive Director |
| Assets £ (m) | 2023 | 2022 | 2021 |
|---|---|---|---|
| Reporting date | 31/12/23 | 31/12/22 | 31/12/21 |
| Intangible asssets and goodwill | 6.53 | 6.4 | 6.22 |
| Investments and other non-current assets | n/a | n/a | n/a |
| Total non-current assets | 8.23 | 8.18 | 7.41 |
| Inventory / work in progress | 2.85 | 3.16 | 2.96 |
| Trade and other receivables | 2.02 | 2.06 | 1.7 |
| Cash and equivalents | 1.21 | 2.2 | 3.64 |
| Other current assets and asset held for resale | n/a | n/a | n/a |
| Total of all assets | 14.32 | 15.6 | 15.72 |
| Liabilities £ (m) | 2023 | 2022 | 2021 |
|---|---|---|---|
| Short term liabilities | 2.62 | 2.92 | 4.14 |
| Long term liabilities | 1.22 | 1.71 | 0.92 |
| Other liabilites / pension etc | n/a | n/a | n/a |
| Total of all liabilities | 3.84 | 4.63 | 5.05 |
| Net assets £ (m) | 2023 | 2022 | 2021 |
|---|---|---|---|
| Net assets | 10.48 | 10.96 | 10.66 |
| Equity £ (m) | 2023 | 2022 | 2021 |
|---|---|---|---|
| Share capital | 9.33 | 9.33 | 9.33 |
| Minority interests | n/a | n/a | n/a |
| Retained earnings | -7.01 | -6.53 | -6.83 |
| Share premium account | 6.59 | 6.59 | 6.59 |
| Total equity | 10.48 | 10.96 | 10.66 |
| Income £ (m) | 2023 | 2022 | 2021 |
|---|---|---|---|
| Turnover | n/a | n/a | n/a |
| Operating profit | -0.6 | 0.04 | -0.46 |
| Pre-tax profit | -0.73 | -0.06 | -0.58 |